Summary The variations in uptake of 3H-vincristine sulphate, given as a bolus i.v. injection, by a transplantable murine tumour during a realistic course of fractionated daily y-radiation of 25 x 2.0 Gy have been investigated. Maximum levels of 3H in the tumours are found when the tracer is injected 4 h after irradiation and the tumours are dissected out 1 h after injection. During the course of daily irradiation the pattern of uptake varies considerably but reproducibly. There are peaks of uptake after 7, 13 and 22 fractions of 2.0 Gy when the amount of 3H in the tumours is as much as three times that found in non-irradiated tumours. After 17-18 fractions, however, the tumour content of 3H is lower than that of non-irradiated tumours. The wave-like pattern of uptake could be due either to capillary occlusion brought about by radiation induced cellular swelling and oedema followed by re-opening of the capillaries during periods of decreased cellularity, or to some mechanism of recovery from radiation damage during the week-end rest period.
The substantial number of recent publications on the subject indicate that the use of combined modality treatment (CMT; Howes, 1988 ) is increasing. In CMT, chemotherapeutic agents are given either before, during or after a course of fractionated radiotherapy.
The choice of the type of chemotherapeutic agent(s) to be administered and the timing of its administration are based or radiobiological principles as well as consideration of normal tissue damage and the general state of health of the patient (Steel, 1988; Brown, 1979; Tubiana et al., 1985) . Thus when oncologists speak of 'radiation-drug interaction' they mean the enhancement of, or protection from, the effects of radiation on normal and/or malignant tissues (Steel, 1979) . Although these considerations are logical and valid there is one effect of radiation which is never taken into account but which may have significant implications for the success or failure of CMT: the effects of radiation on vascular integrity.
It is by now fairly well established that radiation has profound effects on vascular function in the irradiated tissue, resulting in alterations in blood flow (Zanelli & Lucas, 1976) , in the structure of the capillary endothelium (Eddy, 1980) and in the extravasation of plasma macromolecules (Krishnan et al., 1988) . Furthermore, there are indications that the vascular effects of radiation are not random but systematic, i.e. are functions of the radiation dose and the time after radiation, and that the sequence of events is different in normal and malignant tissues (Zanelli & Lucas, 1976) . Although the effects of radiation on cell membranes are less well understood they appear to involve loss of surface lipids (Bacq & Alexander, 1966) leading to loss of integrity and altered permeability to a variety of chemical entities.
One further point of importance in the present context concerns the shape of the cell survival curves following chemotherapy. Although much is known about cell survival curves after irradiation, we know much less about cell survival after chemotherapy. The available evidence (Masters & Hepburn, 1986) During the growth of the tumours (-4 weeks) groups of four mice with tumours of similar size were injected with the tracer, killed 1 h later and the 3H content per unit weight of tumour determined as described above. This was continued until tumours of a mean diameter of -12 mm were obtained and the experiment was then stopped.
Experiment 5 Eight groups of four mice with non-irradiated tumours of similar size (d= 5.8 + 0.6 mm) were injected with 3H-vincristine i.v. and killed at various times (0.5-24 h) after injection. The tumour and blood content of 3H was determined as usual.
Experiment 6 This was the same as experiment 1 (daily irradiations of 2Gy, five days per week for 5 weeks) except that after each fraction a group of four mice was withdrawn and injected 4h after irradiation (lh in experiment 1) and killed 1 h after injection (as for experiment 1). In this experiment only the tumour and blood were collected.
Results
The results of experiment 1 are shown in Figure 1 . There are substantial variations in the uptake of 3H per unit weight of tumour throughout the course of fractionated radiation. After 7 x 2 Gy the amount of tracer in the tumour is more than twice that found at the beginning of the experiment. On the other hand, after 15-18 fractions of 2Gy the uptake falls to about one-third of that on day 1. In this and all subsequent figures the bars represent the standard error of the means. The troughs at 9 and 17 days could be due to a reduction in uptake in larger tumours as shown in Figure 2 , coupled with recovery of the vasculature during the week-end rest period from radiation damage. The peaks appear to be real and suggest increased extravasation of drug through radiation damaged capillary endothelium. Figure 3 shows the percentage of injected dose per gram of liver and lung throughout the course of fractionated tumour irradiation in experiment 1. The uptake in these organs is fairly constant. The growth pattern of the NT tumour with and without irradiation is shown in Figure 4 . This tumour is fairly radioresistant and continues to grow, at a reduced rate, during the radiation treatment (the data points are for a group of mice which had undergone the full 5 week treatment during experiment 1). There is little evidence of tumour control even after 25 fractions of 2Gy. Figure 5 shows that in non-irradiated tumours the uptake of 3H per unit weight remains reasonably constant up to 24h after injection (experiment 5). The amount of tracer in the tumour tissue stays below the concentration in the blood.
Figures 6 and 7 show the pattern of uptake of 3H in tumours given seven fractions of 2 Gy (the peak of uptake in experiment 1, Figure 1 ) with time after irradiation (experiment 2, Figure 6 ) and time after injection (experiment 3, Figure 7 ). They show that the maximum uptake in tumours is achieved if the mice are injected four hours after irradiation and killed one hour after injection. Furthermore, the amount of tracer in the tumours after 7 x 2 Gy of radiation is greater than that in non-irradiated tumours ( Figure 5) and is above the blood concentration. Figure 8 shows the results of experiment 6 in which the experimental conditions have been optimised on the basis of the results of experiments 2 and 3, i.e. the mice were injected 20 25 4h after a given fraction of radiation and killed one hour after injection. The rhythmic pattern of tracer uptake is circles, non- similar to that of experiment 1 (Figure 1 ) but the absolute n 2 Gy daily values are higher, as would be expected from the results shown in Figures 6 and 7 . (Steel, 1979) , to study their mechanisms (Wheeler & Kaufman, 1980; van der Maase, 1984; Joiner et al., 1984) and to propose more realistic models for the study of such interactions in humans (Rubin et al., 1988 (Twentyman et al., 1979; Begg et al., 1979; Collis & Steel, 1983; Pearson & Steel, 1984; Fu et al., 1985 Fu et al., , 1988 ; Lelieveld et al., 1985 (Looney et al., 1985; Tannock & Sindelar, 1988) .
As for possible explanations of the results reported in this paper, the effects of radiation on the tumour vasculature must be the prime candidate. It has been known for a long time that radiation has severe effects on blood flow and extravasation of macromolecules (Zanelli & Lucas, 1976; Song & Levitt, 1970) and has recently been confirmed by Krishnan et al., (1988) Whether the results of the present investigation apply to all drugs and all tumours, especially human tumours, is not known, and neither is the effect of different fractionation regimes. On the basis of the above discussion one would expect all drugs to behave at least qualitatively in a similar manner. However, different tumours and fractionation schedules may show different temporal effects.
As stated in the Introduction the available evidence suggests that the effects of radiation on malignant and normal tissues with respect to extravasation are qualitatively similar but displaced in time. If one has to calculate parameters such as 'therapeutic gain' from CMT experiments it is essential that these temporal differences be investigated during realistic regimes of fractionated radiation, i.e. with experiments of the type reported above on tumours and normal tissues.
Since in clinical practice concurrent radiotherapy and chemotherapy are not only being seriously considered, but actually practised, the above questions are critical. Animal experiments are obviously the quickest way of obtaining answers, but the question still remains of how closely animal models mimic the human situation. The type of experiments described in this paper can be carried out in some types of human cancer where at least one extra biopsy can be taken without undue discomfort to the patients. Alternatively, with modern non-invasive methods of detection (e.g. positron emission tomography) it may be possible to quantitate tissue uptake of therapeutic agents labelled with positron-emitting radionuclides. The authors would like to thank the Italian Cancer Research Society 'La via di Natale' for their generous support.
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